Medirom Healthcare Capex To Revenue Over Time
| MRM Stock | USD 1.05 0.04 3.67% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Medirom Healthcare Performance and Medirom Healthcare Correlation. Medirom |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share (0.15) | Revenue Per Share 1.4 K | Quarterly Revenue Growth (0.06) | Return On Assets (0.04) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capex To Revenue Analysis
Compare Medirom Healthcare and related stocks such as HR Block, Service International, and Rollins Capex To Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HRB | 0.0333 | 0.0295 | 0.039 | 0.0486 | 0.04 | 0.0329 | 0.0294 | 0.0312 | 0.0309 | 0.0309 | 0.0155 | 0.0179 | 0.0201 | 0.0176 | 0.0168 |
| ROL | 0.0216 | 0.0155 | 0.015 | 0.0139 | 0.0204 | 0.0266 | 0.021 | 0.0147 | 0.0149 | 0.0135 | 0.0107 | 0.0112 | 0.0114 | 0.0106 | 0.01 |
| WW | 0.005 | 0.0246 | 0.0311 | 0.0311 | 0.0311 | 0.0311 | 0.0295 | 0.0311 | 0.0311 | 0.0311 | 0.0311 | 0.0311 | 0.0368 | 0.0408 | 0.0428 |
| CSV | 0.3958 | 0.0558 | 0.063 | 0.05 | 0.1047 | 0.1477 | 0.0931 | 0.0635 | 0.0505 | 0.0561 | 0.0461 | 0.0662 | 0.0705 | 0.0472 | 0.0448 |
Medirom Healthcare and related stocks such as HR Block, Service International, and Rollins Capex To Revenue description
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.My Equities
My Current Equities and Potential Positions
| Medirom Healthcare Technologies | MRM |
| Classification | Personal Services |
| Location | Japan |
| Exchange | NASDAQ Exchange |
USD 1.05
Check out Medirom Healthcare Performance and Medirom Healthcare Correlation. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Medirom Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.